-
Loading metrics
Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
- Shuyan Gu,
- Yuhang Zeng,
- Demin Yu,
- Xiaoqian Hu,
- Hengjin Dong
x
- Published: November 22, 2016
- https://doi.org/10.1371/journal.pone.0167190